Mathematical modeling provides kinetic details of the human immune response to vaccination
暂无分享,去创建一个
[1] A. Rothman,et al. Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. , 2002, Virology.
[2] Alan S. Perelson,et al. Different Dynamics of CD4+ and CD8+ T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection 1 , 2003, The Journal of Immunology.
[3] Sebastian Bonhoeffer,et al. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis , 1999, The Lancet.
[4] M. Albert,et al. Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies. , 2010, Blood.
[5] B. Rehermann,et al. Immune responses to HCV and other hepatitis viruses. , 2014, Immunity.
[6] W Chen,et al. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. , 2000, Immunity.
[7] Mark M. Davis,et al. Antiviral memory phenotype T cells in unexposed adults , 2013, Immunological reviews.
[8] Rob J de Boer,et al. A general functional response of cytotoxic T lymphocyte-mediated killing of target cells. , 2014, Biophysical journal.
[9] Alan S. Perelson,et al. Recruitment Times, Proliferation, and Apoptosis Rates during the CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus , 2001, Journal of Virology.
[10] L. Lefrançois,et al. Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. , 2008, Immunity.
[11] F. Guirakhoo,et al. Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All , 2006, Human vaccines.
[12] G. Nossal,et al. Elaboration of antibodies by single cells. , 1962, Annual review of microbiology.
[13] A. Perelson. Modelling viral and immune system dynamics , 2002, Nature Reviews Immunology.
[14] M. Slifka,et al. How advances in immunology provide insight into improving vaccine efficacy. , 2014, Vaccine.
[15] Klaus Rajewsky,et al. The half‐lives of serum immunoglobulins in adult mice , 1988, European journal of immunology.
[16] P. Doherty,et al. Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. , 2010, The Journal of clinical investigation.
[17] J. Hoxie,et al. Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor , 2014, Science Translational Medicine.
[18] David Kotlyar. CD8 T Cells , 2016 .
[19] Christian Stemberger,et al. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. , 2007, Immunity.
[20] R. Ahmed,et al. Cytotoxic T-cell memory without antigen , 1994, Nature.
[21] N. Ferguson,et al. Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.
[22] M. Mbow,et al. Infiltration of CD4+ CD8+ T cells, and expression of ICAM-1, Ia antigens, IL-1 alpha and TNF-alpha in the skin lesion of BALB/c mice undergoing repeated infestations with nymphal Ixodes ricinus ticks. , 1994, Immunology.
[23] F. Trepel,et al. Number and distribution of lymphocytes in man. A critical analysis , 1974, Klinische Wochenschrift.
[24] M. Niedrig,et al. Safety profile of the yellow fever vaccine Stamaril®: a 17-year review , 2013, Expert review of vaccines.
[25] H. Dosch,et al. Limiting dilution analysis of the B cell compartment in human bone marrow , 1986, European journal of immunology.
[26] A S Perelson,et al. Target cell limited and immune control models of HIV infection: a comparison. , 1998, Journal of theoretical biology.
[27] C. Rice,et al. The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD 8 T Cell Response 1 , 2009 .
[28] B. Haynes,et al. Distinct Kinetics of Gag-Specific CD4+ and CD8+ T Cell Responses during Acute HIV-1 Infection , 2012, Journal of Immunology.
[29] R J D B,et al. Target Cell Limited and Immune Control Models of HIV Infection : A Comparison , 1998 .
[30] Uri Hershberg,et al. Taking Advantage: High-Affinity B Cells in the Germinal Center Have Lower Death Rates, but Similar Rates of Division, Compared to Low-Affinity Cells1 , 2009, The Journal of Immunology.
[31] Rate of hemolytic antibody production by single cells in vivo in rabbits. , 1974, Journal of immunology.
[32] J. Altman,et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.
[33] G. Gerna. Endothelial cells and CMV dissemination. , 2012, Future microbiology.
[34] Nichole E Carlson,et al. Duration of humoral immunity to common viral and vaccine antigens. , 2007, The New England journal of medicine.
[35] Susan M. Kaech,et al. Transcriptional control of effector and memory CD8+ T cell differentiation , 2012, Nature Reviews Immunology.
[36] R. Ahmed,et al. Humoral immunity due to long-lived plasma cells. , 1998, Immunity.
[37] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[38] Persephone Borrow,et al. The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.
[39] Philip J. R. Goulder,et al. Phenotypic Analysis of Antigen-Specific T Lymphocytes , 1996, Science.
[40] Claudia Henry,et al. Plaque Forming Cells: Methodology and Theory , 1974, Transplantation reviews.
[41] Vitaly V. Ganusov,et al. Estimating In Vivo Death Rates of Targets due to CD8 T-Cell-Mediated Killing , 2008, Journal of Virology.
[42] M. Slifka. Vaccine-Mediated Immunity Against Dengue and the Potential for Long-Term Protection Against Disease , 2014, Front. Immunol..
[43] Douglas M. Bates,et al. Nonlinear Regression Analysis and Its Applications , 1988 .
[44] Rustom Antia,et al. The role of models in understanding CD8+ T-cell memory , 2005, Nature Reviews Immunology.
[45] Matthew S. Lewis,et al. Immune clearance of highly pathogenic SIV infection , 2013, Nature.
[46] E. Gotuzzo,et al. Efficacy and duration of immunity after yellow fever vaccination: systematic review on the need for a booster every 10 years. , 2013, The American journal of tropical medicine and hygiene.
[47] K. Rajewsky,et al. The bulk of endogenously produced IgG2a is eliminated from the serum of adult C57BL/6 mice with a half‐life of 6–8 days , 1986, European journal of immunology.
[48] P. Doherty,et al. Accessing complexity: the dynamics of virus-specific T cell responses. , 2000, Annual review of immunology.
[49] M. Alyanakian,et al. Pharmacokinetics of total immunoglobulin G and immunoglobulin G subclasses in patients undergoing replacement therapy for primary immunodeficiency syndromes , 2003, Vox sanguinis.
[50] Jeremy Auerbach,et al. Mathematical Modeling Reveals Kinetics of Lymphocyte Recirculation in the Whole Organism , 2014, PLoS Comput. Biol..
[51] R. Ahmed,et al. Insights into human CD8+ T‐cell memory using the yellow fever and smallpox vaccines , 2011, Immunology and cell biology.
[52] R Stalnikowicz-Darvasi,et al. Gastrointestinal bleeding during low-dose aspirin administration for prevention of arterial occlusive events. A critical analysis. , 1995, Journal of clinical gastroenterology.
[53] Bjoern Peters,et al. Naive Precursor Frequencies and MHC Binding Rather Than the Degree of Epitope Diversity Shape CD8+ T Cell Immunodominance1 , 2008, The Journal of Immunology.
[54] G. Pantaleo,et al. Immune response to HIV , 2013, Current opinion in HIV and AIDS.
[55] Lloyd Demetrius,et al. Of mice and men , 2005, EMBO reports.
[56] K. Murali‐Krishna,et al. CD8 T Cell Expansion and Memory Differentiation Are Facilitated by Simultaneous and Sustained Exposure to Antigenic and Inflammatory Milieu1 , 2008, The Journal of Immunology.
[57] Measurement of antibody release from single cells. II. , 1972, Journal of immunology.
[58] Alan S. Perelson,et al. Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.
[59] Patrick C. Wilson,et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.
[60] C. Althaus,et al. Dynamics of CD8+ T Cell Responses during Acute and Chronic Lymphocytic Choriomeningitis Virus Infection1 , 2007, The Journal of Immunology.
[61] I. Turesson. Distribution of immunoglobulin-containing cells in human bone marrow and lymphoid tissues. , 2009, Acta medica Scandinavica.
[62] Susan M. Kaech,et al. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.
[63] A. Govaerts. [Humoral immunity]. , 1978, Bruxelles medical.
[64] I. Messaoudi,et al. Protective immunity following vaccination: How is it defined? , 2008, Human vaccines.
[65] E. Bromage,et al. The third dimension of ELISPOTs: quantifying antibody secretion from individual plasma cells. , 2009, Journal of immunological methods.
[66] Rustom Antia,et al. Estimating the Precursor Frequency of Naive Antigen-specific CD8 T Cells , 2002, The Journal of experimental medicine.
[67] Marion Pepper,et al. Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. , 2007, Immunity.
[68] A. Khoruts,et al. Visualizing the generation of memory CD4 T cells in the whole body , 2001, Nature.
[69] Á. L. Bertho,et al. Detection of Th1/Th2 cytokine signatures in yellow fever 17DD first-time vaccinees through ELISpot assay. , 2008, Cytokine.
[70] David R. Anderson,et al. Model selection and multimodel inference : a practical information-theoretic approach , 2003 .
[71] A. SMIm. Immunoglobulin Synthesis and Total Body Tumor Cell Number in IgG Multiple Myeloma , 2022 .
[72] Roland R. Regoes,et al. Investigating CTL Mediated Killing with a 3D Cellular Automaton , 2009, PLoS Comput. Biol..
[73] M H Lessof,et al. Advances in immunology. , 1978, The Practitioner.
[74] N. K. Jerne,et al. Plaque Formation in Agar by Single Antibody-Producing Cells , 1963, Science.
[75] Libin Rong,et al. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life , 2013, Proceedings of the National Academy of Sciences.
[76] Michael J. Bevan,et al. CD8+ T Cells: Foot Soldiers of the Immune System , 2011, Immunity.
[77] S. Hansen,et al. Duration of antiviral immunity after smallpox vaccination , 2003, Nature Medicine.
[78] Vitaly V. Ganusov,et al. Killing of Targets by CD8+ T Cells in the Mouse Spleen Follows the Law of Mass Action , 2011, PLoS ONE.
[79] Lihan K. Yan,et al. Improved Assay To Detect Neutralizing Antibody following Vaccination with Diluted or Undiluted Vaccinia (Dryvax) Vaccine , 2003, Journal of Clinical Microbiology.
[80] M. Jenkins,et al. The Role of Naive T Cell Precursor Frequency and Recruitment in Dictating Immune Response Magnitude , 2012, The Journal of Immunology.
[81] Dirk Homann,et al. Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory , 2001, Nature Medicine.
[82] J. Salfeld,et al. Isotype selection in antibody engineering , 2007, Nature Biotechnology.